DXC Technology Launches Innovation Centre in London
DXC Technology (NYSE: DXC), the world’s leading independent, end-to-end IT services company, today announced the opening of the DXC Innovation Centre in London for the company and its clients to develop and deliver high-impact digital solutions.
DXC’s London Innovation Centre is a collaborative environment that draws on the company’s global experience in digital transformation, leverages its rich industry knowledge and independent partner network, and creates an environment for the incubation of ideas, learning and development.
The London Innovation Centre adds to DXC’s digital network in the UK, which includes a Digital Transformation Centre in Newcastle that is already helping customers to transform and accelerate the creation of business value. As part of this network, DXC digital technologists and enterprise solution experts will work with customers and partners to modernize and integrate mainstream IT by deploying digital solutions at scale.
“Our Innovation Centre brings together innovative technologies, creative thinking and best practices to develop innovative solutions for clients in a rapidly changing digital era,” said Maruf Majed, vice president and general manager, DXC UK, Ireland, Israel, Middle East and Africa. “The Innovation Centre creates opportunities for our people, clients and partners to gain valuable practical experience with digital technology in real-life business applications.”
Local and Global Digital Ideation
The London Centre showcases emerging digital technologies such as machine learning, artificial intelligence, IoT, blockchain and robotics. There will be a focus on sectors including government, energy and utilities, healthcare and life sciences, travel and transport, insurance, financial services and manufacturing.
As part of DXC’s global network of digital experience centres, the London facility will draw from global teams of digital specialists who are working on digital journey mapping and the co-creation of leading-edge prototypes. The goal is to build enterprise-grade, secure and globally scalable solutions for rapid deployment in customer environments.
Development, Engagement and Experiential Opportunities
The Innovation Centre will create new learning and career development opportunities for DXC employees – including personal and organizational digital skills and capabilities – and will contribute to the wider technology and business communities in the UK.
Initial digital client engagements will focus on:
- Digital Account Opening – For customers interacting digitally with their banking providers, who have an obligation to their customers and are bound by government regulation, to ensure that interactions are carried out lawfully;
- Field Worker Effectiveness – Using the latest voice-controlled headsets and the ability to connect workers using digital workflows, tasks can be carried out efficiently and details uploaded into business systems;
- KPI Dashboard – Providing a C-level view of enterprise key performance indicators; and
- Smart Factory Concept – Increasing productivity through digital manufacturing technologies and IoT.
Representing a view from the DXC Partner Network, Peter Almond, PwC Alliance Director, said: “The launch of DXC’s London Innovation Centre provides PwC with a powerful extension to its own eco-system of customer experience centres and brings the ability to co-create innovative digital solutions that are rooted in the realities that come with deploying technology at scale across complex enterprise environments.”
DXC’s London Innovation Centre will also leverage research and frameworks that address the concepts of “Winning in the 21st Century Organisation” and “Developing the mindsets of 21st Century Humans” from Leading Edge Forum, an independent think tank.
About DXC Technology
As the world's leading independent, end-to-end IT services company, DXC Technology (NYSE: DXC) leads digital transformations for clients by modernizing and integrating their mainstream IT, and by deploying digital solutions at scale to produce better business outcomes. The company’s technology independence, global talent, and extensive partner network enable 6,000 private and public-sector clients in 70 countries to thrive on change. DXC is a recognized leader in corporate responsibility. For more information, visit dxc.technology and explore THRIVE, DXC’s digital destination for changemakers and innovators.
About Leading Edge Forum (LEF)
Leading Edge Forum is an independent think tank, committed to helping clients embrace opportunities created by disruption. With its global ecosystem of industry-leading practitioners, disruptors and innovators, LEF creates progressive research and next-practice advisory interventions that agitate clients to activate change and accelerate impact with their own organizations and customers.
Marketing & Communications Director, UKIIMEA
T +44 20 3882 4422
Corporate Media Relations
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Gilead to Present New Data on HIV Prevention, Treatment and Cure Research at IAS 201918.7.2019 12:30:00 CEST | Press release
Gilead Sciences, Inc. (NASDAQ: GILD) today announced that new data from the company’s HIV research and development programs will be presented at the 10th International AIDS Society Conference on HIV Science (IAS 2019) being held in Mexico City from July 21-24. Fifteen abstracts, along with community-focused symposia and workshops, reflect Gilead’s ongoing commitment to scientific innovation, a key pillar to addressing unmet and evolving medical needs in HIV. “Gilead’s scientific discovery has helped transform both HIV treatment and prevention and we are committed to advancing the next generation of therapies to improve the care of people and communities impacted by this disease,” said John McHutchison, AO, MD, Chief Scientific Officer, Head of Research & Development, Gilead Sciences. “Our data at this year’s meeting include exciting progress in our HIV prevention, treatment and cure programs, which together are helping to advance the field of HIV toward the ultimate goal of ending the
Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics18.7.2019 12:00:00 CEST | Press release
Boehringer Ingelheim and Bridge Biotherapeutics Inc. today announced that they are entering into a new collaboration and license agreement with the goal of developing Bridge Biotherapeutics’s autotaxin inhibitor BBT-877 for patients with fibrosing interstitial lung diseases, including IPF. BBT-877 is currently in Phase I clinical studies and is anticipated to enter Phase II testing within the next 12 months. Both companies will initially focus on developing the compound for the treatment of IPF, an area of high-unmet medical need and one of the key focus areas of Boehringer Ingelheim. Boehringer Ingelheim has developed OFEV® (nintedanib), an antifibrotic drug shown to slow disease progression by reducing lung function decline and currently approved for the treatment of IPF in more than 70 countries around the world including the US, the EU and Japan. IPF is a rare, debilitating and fatal lung disease affecting approximately three million people worldwide. It causes progressive scarring
Quotient Sciences to Recapitalize With Global Private Equity Firm Permira18.7.2019 12:00:00 CEST | Press release
Quotient Sciences and global investment firm Permira today announced that a company backed by the Permira Funds has signed a definitive agreement to acquire a majority stake in Quotient from companies controlled by GHO Capital and other investors for an undisclosed sum. The investment provides substantial new funding to fuel the next stage of Quotient’s growth. Chief Executive Officer Mark Egerton and the management team will continue to lead Quotient. Quotient Sciences has brought innovation to the pharmaceutical services sector through its unique Translational Pharmaceutics® platform, which is proven to accelerate development timelines, reduce development costs, and drive improvement in R&D productivity. The business has experienced substantial growth over recent years and generates annual revenues in excess of £100 million. “We are delighted to partner with Permira to drive Quotient through our continued evolution,” said Mark Egerton, Ph.D., Chief Executive Officer of Quotient Scien
SAMWHA ELECTRIC, a Manufacturer of Electrolytic Capacitor, Strengthens Global Business to Become the Digital Best Company18.7.2019 12:00:00 CEST | Press release
SAMWHA ELECTRIC (KRX:009470), a manufacturer specialized in electrolytic capacitors, is enhancing its global business by focusing on R&D and marketing to meet customers’ needs worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190718005034/en/ SAMWHA ELECTRIC (KRX:009470), a manufacturer specialized in electrolytic capacitors, is enhancing its global business by developing electrolytic capacitors and Green-Cap (EDLC) which are essential to various industries including information technology, 5G telecommunication, eco-friendly cars, medical devices, LED, robots, IoT, wind power, solar power and ESS. In particular, it launched conductive polymer hybrid electrolytic capacitors for automotive electronics and 5G communication devices as 150℃ products with high reliability are needed in both industries. Products and solutions by SAMWHA ELECTRIC (Graphic: Business Wire) In tandem with increasing needs of high-value eco-frien
SimpleCommands Introduces Voice Clips with support for Sonos Speakers, including Ikea Symfonisk speakers18.7.2019 09:11:00 CEST | Press release
Today, SimpleCommands announced the newest addition to the kloee platform, Voice Clips—including support for Sonos Speakers and Ikea Symfonisk speakers as well as other locally connected audio devices. SimpleCommands Voice Clips are short human voice audio clips that you can create on demand with the SimpleCommands app or web dashboard. With SimpleCommands you can control and automate many of the most popular smart home services and products and integrate them with SimpleCommands Voice Clips. Supported Voice Clip devices include: Sonos One, Sonos Beam, Sonos 5 (gen 2) and Ikea Symfonisk speakers. “Since we launched SimpleCommands, customers have told us they love getting a notification when their schedule or other automated routine executes. It’s nice to know which specific smart-cam saw a person or when a young driver arrives at their destination. Maybe you just want a daily voice reminder that lets your kids know that it is homework time. You can also build Voice Clips that will prom
Samsung Begins Mass Production of Industry’s First 12Gb LPDDR5 Mobile DRAM for Premium Smartphones18.7.2019 09:00:00 CEST | Press release
Samsung Electronics Co., Ltd., the world leader in advanced memory technology, today announced that it has begun mass producing the industry’s first 12-gigabit (Gb) LPDDR5 mobile DRAM, which has been optimized for enabling 5G and AI features in future smartphones. The new mobile memory comes just five months after announcing mass production of the 12GB LPDDR4X, further reinforcing the company’s premium memory lineup. Samsung also plans to start mass producing 12-gigabyte (GB) LPDDR5 packages later this month, each combining eight of the 12Gb chips, in line with growing demand for higher smartphone performance and capacity from premium smartphone manufacturers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190718005257/en/ Samsung 12Gb LPDDR5 (Photo: Business Wire) “With mass production of the 12Gb LPDDR5 built on Samsung’s latest second-generation 10-nanometer (nm) class process, we are thrilled to be supporting the timely